Genomma Lab Internacional... (GNMLF)
Genomma Lab Internacional S.A.B. de C.V. Statistics
Share Statistics
Genomma Lab Internacional S.A.B. de C.V. has 1B shares outstanding. The number of shares has increased by -1.96% in one year.
| Shares Outstanding | 1B |
| Shares Change (YoY) | -1.96% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 670.36M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 11.72 and the forward PE ratio is null. Genomma Lab Internacional S.A.B. de C.V.'s PEG ratio is 0.
| PE Ratio | 11.72 |
| Forward PE | n/a |
| PS Ratio | 1.35 |
| Forward PS | n/a |
| PB Ratio | 2.16 |
| P/FCF Ratio | 8.97 |
| PEG Ratio | 0 |
Enterprise Valuation
Genomma Lab Internacional S.A.B. de C.V. has an Enterprise Value (EV) of 27.73B.
| EV / Sales | 1.49 |
| EV / EBITDA | 6.7 |
| EV / EBIT | 9.18 |
| EV / FCF | 9.93 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.44.
| Current Ratio | 1.84 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | 1.22 |
| Debt / FCF | 1.81 |
| Interest Coverage | 4.49 |
Financial Efficiency
Return on Equity is 18.44% and Return on Invested Capital is 16.99%.
| Return on Equity | 18.44% |
| Return on Assets | 8.87% |
| Return on Invested Capital | 16.99% |
| Revenue Per Employee | $11.59M |
| Profits Per Employee | $1.33M |
| Employee Count | 1,605 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 3.07 |
Taxes
| Income Tax | 753.78M |
| Effective Tax Rate | 26.07% |
Stock Price Statistics
The stock price has increased by 34.78% in the last 52 weeks. The beta is 0.55, so Genomma Lab Internacional S.A.B. de C.V.'s price volatility has been higher than the market average.
| Beta | 0.55 |
| 52-Week Price Change | 34.78% |
| 50-Day Moving Average | 1.42 |
| 200-Day Moving Average | 1.23 |
| Relative Strength Index (RSI) | 10.85 |
| Average Volume (20 Days) | 29 |
Income Statement
In the last 12 months, Genomma Lab Internacional S.A.B. de C.V. had revenue of 18.61B and earned 2.14B in profits. Earnings per share was 2.26.
| Revenue | 18.61B |
| Gross Profit | 11.93B |
| Operating Income | 3.98B |
| Net Income | 2.14B |
| EBITDA | 4.14B |
| EBIT | 3.78B |
| Earnings Per Share (EPS) | 2.26 |
Balance Sheet
The company has 2.38B in cash and 5.06B in debt, giving a net cash position of -2.69B.
| Cash & Cash Equivalents | 2.38B |
| Total Debt | 5.06B |
| Net Cash | -2.69B |
| Retained Earnings | 12.21B |
| Total Assets | 24.08B |
| Working Capital | 5.65B |
Cash Flow
In the last 12 months, operating cash flow was 3.02B and capital expenditures -227.52M, giving a free cash flow of 2.79B.
| Operating Cash Flow | 3.02B |
| Capital Expenditures | -227.52M |
| Free Cash Flow | 2.79B |
| FCF Per Share | 2.96 |
Margins
Gross margin is 64.12%, with operating and profit margins of 21.4% and 11.49%.
| Gross Margin | 64.12% |
| Operating Margin | 21.4% |
| Pretax Margin | 15.54% |
| Profit Margin | 11.49% |
| EBITDA Margin | 22.24% |
| EBIT Margin | 21.4% |
| FCF Margin | 15.01% |
Dividends & Yields
GNMLF pays an annual dividend of $0.62, which amounts to a dividend yield of 29.38%.
| Dividend Per Share | $0.62 |
| Dividend Yield | 29.38% |
| Dividend Growth (YoY) | -94.78% |
| Payout Ratio | 560.19% |
| Earnings Yield | 8.53% |
| FCF Yield | 11.15% |
Analyst Forecast
Currently there are no analyst rating for GNMLF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 1.79 |
| Piotroski F-Score | 8 |